M. Neil Reaume
-
- Renal cell carcinoma treatment 21
- Prostate Cancer Treatment and Research 18
- Lung Cancer Treatments and Mutations 7
- Oncology top 5%
- Hematology top 5%
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 9
- Cancer Genomics and Diagnostics 7
- Biochemistry top 10%
-
- Renal and related cancers 9
-
- Economic and Financial Impacts of Cancer 8
-
- Bladder and Urothelial Cancer Treatments 8
- Co-authors
- Anita LloydTony ReimanScott KlarenbachBrenda R. HemmelgarnBraden MannsMarcello TonelliNatasha WiebeEric Winquist
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
M. Neil Reaume
63 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 68
- Pulmonary and Respiratory Medicine 642
- Oncology 461
- Hematology 162
- Cancer Research 218
- Biochemistry 42
Countries citing papers authored by M. Neil Reaume
This map shows the geographic impact of M. Neil Reaume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Neil Reaume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Neil Reaume more than expected).
Fields of papers citing papers by M. Neil Reaume
This network shows the impact of papers produced by M. Neil Reaume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Neil Reaume. The network helps show where M. Neil Reaume may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Neil Reaume, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 0 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 6 | |
| 8 | 2019 | 6 | |
| 9 | 2018 | 9 | |
| 10 | 2018 | 46 | |
| 11 | 2018 | 10 | |
| 12 | 2017 | 28 | |
| 13 | 2016 | 3 | |
| 14 | 2014 | 6 | |
| 15 | 2013 | 29 | |
| 16 | 2013 | 110 | |
| 17 | 2013 | 8 | |
| 18 | 2013 | 37 | |
| 19 | 2009 | 157 | |
| 20 | 2006 | 50 |
About M. Neil Reaume
M. Neil Reaume is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 66 papers that have together received 1.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (21 papers), Prostate Cancer Treatment and Research (18 papers), Renal and related cancers (9 papers), Cancer, Lipids, and Metabolism (9 papers), Economic and Financial Impacts of Cancer (8 papers), Bladder and Urothelial Cancer Treatments (8 papers), Cancer Genomics and Diagnostics (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (642 citations), Oncology (461 citations) and Hematology (162 citations). M. Neil Reaume has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Anita Lloyd, Tony Reiman, Scott Klarenbach, Brenda R. Hemmelgarn, Braden Manns, Marcello Tonelli, Natasha Wiebe, Eric Winquist, Srikala S. Sridhar and Som D. Mukherjee.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.